G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 102 filers reported holding G1 THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 0.05 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $11,657 | -86.5% | 8,095 | -76.6% | 0.00% | -100.0% |
Q2 2023 | $86,030 | +373943.5% | 34,550 | +310.2% | 0.00% | +200.0% |
Q1 2023 | $23 | -50.0% | 8,423 | +1.1% | 0.00% | -50.0% |
Q4 2022 | $46 | -100.0% | 8,328 | -52.1% | 0.00% | -50.0% |
Q3 2022 | $217,000 | +1569.2% | 17,404 | +549.4% | 0.00% | – |
Q2 2022 | $13,000 | -86.3% | 2,680 | -78.7% | 0.00% | -100.0% |
Q1 2022 | $95,000 | -62.3% | 12,584 | -49.0% | 0.00% | -75.0% |
Q4 2021 | $252,000 | +54.6% | 24,680 | +103.7% | 0.00% | 0.0% |
Q3 2021 | $163,000 | -45.5% | 12,115 | -11.1% | 0.00% | -50.0% |
Q2 2021 | $299,000 | +647.5% | 13,625 | +718.8% | 0.01% | +700.0% |
Q1 2021 | $40,000 | -78.5% | 1,664 | -83.9% | 0.00% | -83.3% |
Q4 2020 | $186,000 | +226.3% | 10,340 | +111.6% | 0.01% | +500.0% |
Q3 2020 | $57,000 | -51.7% | 4,887 | +0.7% | 0.00% | -80.0% |
Q2 2020 | $118,000 | +413.0% | 4,854 | +133.4% | 0.01% | +400.0% |
Q1 2020 | $23,000 | +475.0% | 2,080 | +1123.5% | 0.00% | – |
Q3 2019 | $4,000 | 0.0% | 170 | +112.5% | 0.00% | – |
Q3 2018 | $4,000 | -86.2% | 80 | -93.1% | 0.00% | -100.0% |
Q3 2017 | $29,000 | +222.2% | 1,156 | +110.6% | 0.00% | +100.0% |
Q2 2017 | $9,000 | – | 549 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Cormorant Asset Management, LP | 994,287 | $19,041,000 | 1.55% |
HHLR ADVISORS, LTD. | 949,431 | $18,182,000 | 0.75% |
BB BIOTECH AG | 671,925 | $12,867,000 | 0.41% |
Rhenman & Partners Asset Management AB | 172,820 | $3,310,000 | 0.38% |
Birchview Capital, LP | 15,000 | $287,000 | 0.27% |
Rock Springs Capital Management LP | 100,000 | $1,915,000 | 0.09% |
SECOR Capital Advisors, LP | 32,591 | $624,000 | 0.08% |
MARSHALL WACE, LLP | 386,510 | $7,402,000 | 0.08% |
SIGNATUREFD, LLC | 37,942 | $727,000 | 0.07% |
A.R.T. Advisors, LLC | 38,125 | $730,000 | 0.05% |